Ionis Pharmaceuticals competitorsClear all

Ionis Pharmaceuticals's top competitors include Intellia Therapeutics, Ultragenyx Pharmaceutical, Bluebird Bio, Sarepta Therapeutics, Reata Pharmaceuticals, Arrowhead Pharmaceuticals and Alnylam Pharmaceuticals.

Save Comparison	Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.	Intellia Therapeutics Intellia is developing therapeutic products to help people with genetic diseases.	Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.	Bluebird Bio Bluebird Bio is a developer of gene therapies for severe genetic diseases and cancer.	Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.	Reata Pharmaceuticals Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.	Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.	Alnylam Pharmaceuticals Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Founding Date	Founding Date 1989	Founding Date 2014	Founding Date 2010	Founding Date 1992	Founding Date 1980	Founding Date 2002	Founding Date 2004	Founding Date 2002
Type	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics oncology	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development genetics life sciences	Tags Healthcare biotech healthtech pharma
Locations	Locations Carlsbad, US HQ	Locations Cambridge, US HQ	Locations Novato, US HQ	Locations Cambridge, US HQ Paris, FR München, DE Athens, GR Milano, IT Utrecht, NL Zug, CH see more	Locations Cambridge, US HQ Boulogne Billancourt, FR Berlin, DE Dublin, IE Milano, IT Chiyoda City, JP see more	Locations Plano, US HQ Irving, US Plano, US	Locations Pasadena, US HQ Madison, US San Diego, US	Locations Cambridge, US HQ Paris, FR Milano, IT Amsterdam, NL Stockholm, SE Zug, CH Maidenhead, GB
Employees	Employees 7577% decrease	Employees 27028% increase	Employees 74021% increase	Employees 1,2134% increase	Employees 74349% increase	Employees 22079% increase	Employees 13416% increase	Employees 1,32324% increase
Valuation ($)	Valuation ($) 5.1 b	Valuation ($) 11 b	Valuation ($) 6.4 b	Valuation ($) 1.2 b	Valuation ($) 6.4 b	Valuation ($) 3.9 b	Valuation ($) 6.5 b	Valuation ($) 22.1 b
Twitter followers	Twitter followers 3.5 k	Twitter followers 8.7 k	Twitter followers N/A	Twitter followers 9.7 k	Twitter followers 3.7 k	Twitter followers 1.2 k	Twitter followers 2.8 k	Twitter followers 14.3 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) 4	Number of tweets (last 30 days) 16	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 13	Number of tweets (last 30 days) 19	Number of tweets (last 30 days) 22	Number of tweets (last 30 days) 5	Number of tweets (last 30 days) 14
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 6.5	Average likes per tweet (last 30 days) 11.6	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 2.8	Average likes per tweet (last 30 days) 29.8	Average likes per tweet (last 30 days) 3.1	Average likes per tweet (last 30 days) 35	Average likes per tweet (last 30 days) 7.9
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 61.54%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 95.45%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%
Alexa Website Rank	Alexa Website Rank 280538	Alexa Website Rank 313292	Alexa Website Rank 260258	Alexa Website Rank 319875	Alexa Website Rank 181719	Alexa Website Rank 426642	Alexa Website Rank 157335	Alexa Website Rank 271609
Employee Rating	Employee Rating 3.7	Employee Rating 3.9	Employee Rating 4.3	Employee Rating 3.4	Employee Rating 3.5	Employee Rating 4	Employee Rating 4	Employee Rating 4.2
Financial
Revenue (est.)	Revenue (est.) $729.3m (FY, 2020)	Revenue (est.) $58m (FY, 2020)	Revenue (est.) $271m (FY, 2020)	Revenue (est.) $250.7m (FY, 2020)	Revenue (est.) $540.1m (FY, 2020)	Revenue (est.) $9m (FY, 2020)	Revenue (est.) $168.8m (FY, 2019)	Revenue (est.) $492.9m (FY, 2020)
Cost of goods	Cost of goods $11.9m (FY, 2020)	Cost of goods N/A	Cost of goods N/A	Cost of goods $5.4m (FY, 2020)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $78.1m (FY, 2020)
Gross profit	Gross profit $717.3m (FY, 2020)	Gross profit $58m (FY, 2020)	Gross profit N/A	Gross profit $245.3m (FY, 2020)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $414.8m (FY, 2020)
Net income	Net income ($486.8m) (FY, 2020)	Net income ($134.2m) (FY, 2020)	Net income ($186.6m) (FY, 2020)	Net income ($618.7m) (FY, 2020)	Net income ($554.1m) (FY, 2020)	Net income ($247.8m) (FY, 2020)	Net income $68m (FY, 2019)	Net income ($858.3m) (FY, 2020)
Operating ⚠
Patents Issued	Patents Issued N/A	Patents Issued N/A	Patents Issued N/A	Patents Issued N/A	Patents Issued N/A	Patents Issued 240 (FY, 2016)	Patents Issued 359 (FY, 2016)	Patents Issued N/A
Phase I Trials Products	Phase I Trials Products 6 (FY, 2020)	Phase I Trials Products N/A	Phase I Trials Products N/A	Phase I Trials Products N/A	Phase I Trials Products N/A	Phase I Trials Products 2 (FY, 2016)	Phase I Trials Products N/A	Phase I Trials Products N/A
Phase II Trials Products	Phase II Trials Products 24 (FY, 2020)	Phase II Trials Products N/A	Phase II Trials Products N/A	Phase II Trials Products N/A	Phase II Trials Products N/A	Phase II Trials Products 4 (FY, 2016)	Phase II Trials Products N/A	Phase II Trials Products N/A
Phase III Trials Products	Phase III Trials Products 6 (FY, 2020)	Phase III Trials Products N/A	Phase III Trials Products N/A	Phase III Trials Products N/A	Phase III Trials Products N/A	Phase III Trials Products 1 (FY, 2016)	Phase III Trials Products N/A	Phase III Trials Products N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 200.1m	Total funding raised $ 409m	Total funding raised N/A	Total funding raised $ 468.9m	Total funding raised $ 147.1m	Total funding raised $ 1.5b